Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
82.19
+1.39 (1.72%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Cytokinetics Employees
Cytokinetics had 673 employees as of December 31, 2025. The number of employees increased by 175 or 35.14% compared to the previous year.
Employees
673
Change (1Y)
175
Growth (1Y)
35.14%
Revenue / Employee
$157,229
Profits / Employee
-$1,232,704
Market Cap
11.16B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Ionis Pharmaceuticals | 1,402 |
| Axsome Therapeutics | 1,220 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| Krystal Biotech | 295 |
CYTK News
- 3 days ago - Cytokinetics price target raised to $118 from $100 at Mizuho - TheFly
- 9 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Cytokinetics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program - GlobeNewsWire
- 23 days ago - Cytokinetics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Cytokinetics launches Myqorzo in Germany - TheFly
- 26 days ago - Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany - GlobeNewsWire
- 4 weeks ago - Cytokinetics to Participate in June Investor Conferences - GlobeNewsWire